Press Release (ePRNews.com) - La Jolla, CA - Jan 20, 2017 - Data4Cure Inc., a biomedical data-to-knowledge company, announced today that Janusz Dutkowski, PhD, Data4Cure’s CEO will chair a session and give a presentation at the upcoming 2017 Precision Medicine World Conference (PMWC). The conference will be held in Mountain View, CA between January 23 and 25.
The session, scheduled for the morning of January 24, will also feature a presentation by Pallavi Sachdev, MPH, PhD, Director of Oncology Biomarker Research, Eisai Inc.
The two talks will showcase the utility of molecular subtyping in clinical drug development. In cancer, deep molecular and immune-infiltrate characterization and subtyping has the potential to identify molecular subsets that will benefit from targeted agents and immunotherapy as well as guide the development of combination therapies to combat single-agent resistance.
The session will focus on application of large-scale NGS data, and will highlight some of the unique aspects of Data4Cure’s Biomedical Intelligence® Cloud in the context of molecular subtyping and mapping disease and therapeutic pathways.
“We are excited to be part of this leading conference that gathers global thought leaders in precision medicine,” said Dutkowski. “I am proud of Data4Cure’s role in advancing bioinformatics and biomedical big data analytics which are the key to precision medicine and an important tool in the race for new cures.”
Data4Cure Inc. helps pharmaceutical and healthcare organizations grow knowledge from genomic, molecular and clinical data. The company’s Biomedical Intelligence® Cloud turns large and diverse datasets into a continuously updated biomedical knowledge graph spanning thousands of biological entities and millions of relations. It helps researchers discover key molecular networks underlying disease and drug response, and facilitates the translation of data to knowledge. Learn more at http://www.data4cure.com.
Maja Gawronska Source :